Agreement signed to advance therapy for autoimmune disease
HanAll Biopharma’s licensed partner, Harbour BioMed, has signed an exclusive sublicense agreement with CSPC NBP…
October 12, 2022 - 3 minutes
HanAll Biopharma’s licensed partner, Harbour BioMed, has signed an exclusive sublicense agreement with CSPC NBP…
Nuance Pharma and its partner Verona Pharma plc have received clearance from the Center of…